CLINICAL ROLE -
Dapagliflozin: Benefits in Heart Failure Patients With and Without Diabetes
A new study has found that patients with heart failure with reduced ejection fraction receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular events.
Read More